Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/52785
Full metadata record
DC FieldValueLanguage
dc.creatorMachado, Diogo Alcino de Abreu Ribeiro Carvalhopt_PT
dc.date.accessioned2011-02-27T00:20:07Z-
dc.date.available2011-02-27T00:20:07Z-
dc.date.created2009pt_PT
dc.date.issued2011-02-27-
dc.date.submitted2010-07-28pt_PT
dc.identifier.other041001042pt_PT
dc.identifier.urihttp://hdl.handle.net/10216/52785-
dc.descriptionMedicinapt_PT
dc.descriptionMedicinept_PT
dc.format.mimetypeapplication/pdfpt_PT
dc.languageporpt_PT
dc.publisherInstituto de Ciências Biomédicas Abel Salazarpt_PT
dc.publisherICBASpt_PT
dc.rightsopenAccesspt_PT
dc.subjectPortopt_PT
dc.titleMyelodysplastic Syndromes - Therapeutic options in high-risk patients.pt_PT
dc.typeDissertaçãopt_PT
Appears in Collections:ICBAS - Dissertação



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.